GO
Loading...

Drugs

More

  • District Court judge on Tuesday stopped Massachusetts from implementing a ban on the sale of Zogenix Inc's prescription painkiller Zohydro, saying federal law superceded the state's action.

  • Luis Videgaray, finance minister of Mexico, says the U.S. must "share responsibility" for tackling drug cartels.

  • WASHINGTON, April 10- The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.

  • Pfizer CEO worries about ACA coverage     Thursday, 10 Apr 2014 | 11:43 AM ET

    Ian Read, Pfizer CEO, discusses the pricing and affordability of drugs in the U.S. Read also weighs in on insurance coverage under the Affordable Care Act.

  • Diversifying your pharma portfolio     Monday, 7 Apr 2014 | 1:07 PM ET

    Mallinckrodt is buying drug maker Questcor for $5.6 billion. Barbara Ryan, FTI Consulting managing director, discusses consolidation in pharmaceuticals and shares what stocks she likes in the space.

  • Why this $84,000 drug costs just $900 abroad Saturday, 29 Mar 2014 | 2:29 PM ET

    Why do some drugs, like Gilead's Sovaldi, cost more in the U.S. than in other countries. Shelia Dharmarajian reports for "Nightly Business Report."

  • CALGARY, Alberta, March 27- Canada's largest oil producer, Suncor Energy Inc, said on Thursday it will appeal a legal decision preventing the company from carrying out random drug and alcohol tests on workers at its northern Alberta oil sands sites.

  • 'Eye-opening' new report about statin eligibility Wednesday, 19 Mar 2014 | 5:06 PM ET
    Lipitor tablets

    Almost half of Americans ages 40 to 75 qualify to consider cholesterol-lowering statin drugs under new heart disease prevention guidelines.

  • Zogenix shares fall after Purdue advances rival drug Wednesday, 12 Mar 2014 | 9:37 AM ET

    March 12- Shares of Zogenix Inc fell 14 percent after Purdue Pharma LP said it was moving ahead with an abuse-resistant rival to Zogenix's much-criticised painkiller.

  • The Zohydro debate: More harm than good?     Tuesday, 11 Mar 2014 | 3:20 PM ET

    Powerful new pain killer Zohydro, is prescribed to help people with chronic pain. Dr. Andrew Kolodny thinks the FDA has put out a drug that will kill people. Dr. Steven Garner, New York Methodist Hospital, thinks the drug will help many people who are suffering with lasting pain.

  • Controversial drug Zohydro here to stay?     Tuesday, 11 Mar 2014 | 1:00 PM ET

    CNBC's Sheila Dharmarajan discusses the new pain killer Zohydro which contains the same addictive elements as Oxycodone.

  • The opioid drug, manufactured by Zogenix Inc, contains a potent amount of an active ingredient that could be lethal to new patients and children and is not safer than other current pain drugs, the groups told the Food and Drug Administration. In December, attorneys general from 28 states also urged the FDA to reconsider its approval of the drug.

  • Groups urge FDA to halt launch of Zohydro pain drug Thursday, 27 Feb 2014 | 12:42 PM ET

    The opioid drug, manufactured by Zogenix Inc, contains a potent amount of an active ingredient that could be lethal to new patients and children and is not safer than other current pain drugs, the groups told the Food and Drug Administration. In December, attorneys general from 28 states also urged the FDA to reconsider its approval of the drug.

  • The go-to guy: A conversation with a drug dealer Wednesday, 26 Feb 2014 | 3:25 PM ET

    While out exploring marijuana's first legal frontier, CNBC took a moment to catch up with one young man who has stayed on the darker side of weed—the illegal side.

  • Dabs—marijuana's explosive secret Wednesday, 26 Feb 2014 | 12:37 PM ET
    Nicholas Broms, who was involved in a drug-related explosion last November. Broms was one of the growing number of casualties from manufacturing hash oil, a potent marijuana byproduct made with butane.

    From exploding kitchens to super-intense highs, making and smoking marijuana concentrate—aka “dabs”—is getting more attention in the move toward legalization.

  • Open Vape: The e-cigarette of legal pot Wednesday, 26 Feb 2014 | 12:12 PM ET

    Todd Mitchem's company, Open Vape, manufactures a product similar to an e-cigarette. It's a pen that heats a cartridge filled with purified cannabis oil.

  • Jane West: Wife, mother and 'potrepreneur' Tuesday, 25 Feb 2014 | 5:49 PM ET

    West, who lives in an affluent Denver suburb, calls herself "one part Martha Stewart and one part Walter White."

  • Colorado cannabis: It’s not your grandma’s joint Tuesday, 25 Feb 2014 | 12:55 PM ET
    Sative Blondie Mix

    When it comes to recreational marijuana, forget the joint! People in Colorado are enjoying cannabis in brand new ways, including edibles, drinks, dabs and more.

  • Pot: How two cities are handling it differently Monday, 24 Feb 2014 | 10:47 AM ET

    About 60 miles northeast of Denver a battle between legal marijuana is going on. While Greeley, Colo., is shunning marijuana, neighboring Garden City is celebrating it.

  • New pot banking rules     Friday, 14 Feb 2014 | 2:01 PM ET

    NBC's Pete Williams reports the government has issued guidance for banks servicing legal marijuana businesses. CNBC's Jane Wells provides insight.